D. O'Toole - 09 Jan 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Financial Officer
Signature
/s/ David D. O'Toole
Issuer symbol
OPNT
Transactions as of
09 Jan 2023
Transactions value $
-$8,383
Form type
4
Filing time
09 Jan 2023, 16:16:08 UTC
Previous filing
05 Jan 2023
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$8.38K -415 -1.18% $20.20 34.8K 09 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.